Search research articles
Contact Us
Filters
Showing results (71-80 of 103) with videos related to
Page
of 11
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 15, 2017
U.S. FDA Approval Summary: Nivolumab for Treatment of Unresectable or Metastatic Melanoma Following Progression on Ipilimumab
Maitreyee Hazarika, Meredith K Chuk, Marc R Theoret, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 2024
FDA Approval Summary: Asciminib for Ph+ CML in Chronic Phase Treated with Two or More Tyrosine Kinase Inhibitors and for the T315I Mutation
Gulsum E Pamuk, Edwin C Y Chow, Alexei C Ionan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 19, 2025
Overall Survival and the Evolving Benefit-Risk Assessment for Poly (ADP-ribose) Polymerase Inhibitors in Advanced Ovarian Cancer
Mirat Shah, Ting-Yu Chen, Gwynn Ison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 3, 2020
FDA Approval Summary: Atezolizumab Plus Bevacizumab for the Treatment of Patients with Advanced Unresectable or Metastatic Hepatocellular Carcinoma
Sandra J Casak, Martha Donoghue, Lola Fashoyin-Aje, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 5, 2024
Perspectives on Drug Development for the Treatment of Chronic Myeloid Leukemia in Pregnant Patients and Patients Who Are Breastfeeding
Jorge E Cortes, Elisabetta Abruzzese, Elyce H Cardonick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 23, 2020
FDA Approval Summary: Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Carcinoma
Elaine Chang, Chana Weinstock, Lijun Zhang, et al.
The Oncologist
|
July 1, 2021
Systematic Review of PD-1/PD-L1 Inhibitors in Oncology: From Personalized Medicine to Public Health
Elaine Chang, Lorraine Pelosof, Steven Lemery, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2024
Improving Collection and Analysis of Overall Survival Data
Lisa R Rodriguez, Nicole J Gormley, Ruixiao Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 2020
Regulatory Considerations for Contribution of Effect of Drugs Used in Combination Regimens: Renal Cell Cancer Case Studies
Jamie R Brewer, Elaine Chang, Sundeep Agrawal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 7, 2022
FDA Approval Summary: Pemigatinib for Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusion or Other Rearrangement
Timil H Patel, Leigh Marcus, M Naomi Horiba, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 103) with videos related to
Sort By:
Page
of 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 15, 2017
U.S. FDA Approval Summary: Nivolumab for Treatment of Unresectable or Metastatic Melanoma Following Progression on Ipilimumab
Maitreyee Hazarika, Meredith K Chuk, Marc R Theoret, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 2024
FDA Approval Summary: Asciminib for Ph+ CML in Chronic Phase Treated with Two or More Tyrosine Kinase Inhibitors and for the T315I Mutation
Gulsum E Pamuk, Edwin C Y Chow, Alexei C Ionan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 19, 2025
Overall Survival and the Evolving Benefit-Risk Assessment for Poly (ADP-ribose) Polymerase Inhibitors in Advanced Ovarian Cancer
Mirat Shah, Ting-Yu Chen, Gwynn Ison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 3, 2020
FDA Approval Summary: Atezolizumab Plus Bevacizumab for the Treatment of Patients with Advanced Unresectable or Metastatic Hepatocellular Carcinoma
Sandra J Casak, Martha Donoghue, Lola Fashoyin-Aje, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 5, 2024
Perspectives on Drug Development for the Treatment of Chronic Myeloid Leukemia in Pregnant Patients and Patients Who Are Breastfeeding
Jorge E Cortes, Elisabetta Abruzzese, Elyce H Cardonick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 23, 2020
FDA Approval Summary: Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Carcinoma
Elaine Chang, Chana Weinstock, Lijun Zhang, et al.
The Oncologist
|
July 1, 2021
Systematic Review of PD-1/PD-L1 Inhibitors in Oncology: From Personalized Medicine to Public Health
Elaine Chang, Lorraine Pelosof, Steven Lemery, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2024
Improving Collection and Analysis of Overall Survival Data
Lisa R Rodriguez, Nicole J Gormley, Ruixiao Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 2020
Regulatory Considerations for Contribution of Effect of Drugs Used in Combination Regimens: Renal Cell Cancer Case Studies
Jamie R Brewer, Elaine Chang, Sundeep Agrawal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 7, 2022
FDA Approval Summary: Pemigatinib for Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusion or Other Rearrangement
Timil H Patel, Leigh Marcus, M Naomi Horiba, et al.
Page
of 11